Title: Study of Cardiovascular Complications in Long Term Diabetes Mellitus- An Indian Perspective

Authors: Kausik Maji, Chandra Narayan Gupta, Sukanta Sen

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i8.195

Abstract

Background: Diabetes mellitus is a disorder in which the body is unable to metabolize carbohydrates properly. In view of the above facts the study was undertaken to know the incidence of cardiovascular complications, to establish its relationship with duration of disease; severity of diabetes mellitus; its state of control, the body weight and the type of treatment patient was receiving. An attempt was also taken to find out the interrelationship between different complications.

Materials & Methods: The present study includes adult cases of diabetics who were attended and /or admitted to Medicine and Cardiology wards of a tertiary care teaching hospital, Haldia, West Bengal. All the known cases of diabetics of more than 5 years duration on antidiabetic treatment were included in the study. Fasting blood sugar, post prandial blood sugar, serum cholesterol routine urine examination for reducing substances, albumin, ketone bodies and microalbuminuria were examined. Measurement of HbA1C done in all 106 cases and categorized into good controlled, moderately controlled and poorly controlled. The patients of more than 5 years duration with diabetes were taken as long term diabetics and the long diabetics were divided into two groups as diabetics <10 yrs and diabetics of >10 yrs.

Results: It was observed from table 4 that out of 106 cases, 25 (23.8%) were of severe variety, 35 cases (33%) were of moderate variety and 46 cases (43.2%) were of mild variety. In all instances males were outnumbered females. The incidence of hypertension in good, moderate and poor controlled groups was 12.5%, 18.85 and 66.75% respectively.

Conclusion: Good control of diabetes decreased the incidence of micro and macrovascular complications. Obesity, IHD and hypertension are interrelated. Severity of diabetes was not related to incidence of IHD, hypertension and PVD. CVA and cardiomyopathy showed a more incidence in severe diabetics with an incidence of 58% and 50% respectively.

Keywords: Diabetes Mellitus; Cardiovascular complications, Outcome.

References

  1. De Fronzo RA, Ferrannini E, Zimmet P, et al. International Textbook of Diabetes Mellitus, 2 Volume Set, 4th Edition. Wiley-Blackwell, 2015.
  1. Evans JM, Newton RW, Ruta DA, et al. Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus. Diabet Med J Br Diabet Assoc 2000; 17: 478–80.
  2. Bruno G, Runzo C, Cavallo-Perin P, et al. Incidence of Type 1 and Type 2 Diabetes in Adults Aged 30–49 Years: The population-based registry in the province of Turin, Italy. Diabetes Care 2005; 28: 2613– 19.
  3. Holman N, Young B, Gadsby R. Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med J Br Diabet Assoc 2015; 32: 1119–20.
  4. Prevalence and projections. IDF Diabetes Atlas - 8th Edition. http://diabetesatlas.org/resources/2017-atlas.html. [Accessed on 24 July 2018]
  5. http://www.who.int/news-room/fact-sheets/detail/diabetes. [Accessed on 24 July 2018]
  6. Fendler W, Borowiec M, Baranowska-Jazwiecka A, et al. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia 2012; 55: 2631–35.
  1. Kalofoutis C, Piperi C, Kalofoutis A, Harris F, Phoenix D, Singh J. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches. Experimental & Clinical Cardiology. 2007;12(1):17-28.
  2. Al-Nozha MM, Ismail HM, Nozha OMA. Coronary artery disease and diabetes mellitus. Journal of Taibah University Medical Sciences 2016; 11(4): 330-338.
  3. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes. Diabetes Care 2003; 26:1374–1379.
  4. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, et al. the EURODIAB Prospective Complications Study Group: Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004;27:530–537.
  5. Michael E. Farkouh, Elliot J Rayfield, Valentin Fuster. Diabetes and cardiovascular disease. Chapter 78, page 21-97-2212.
  1. Ramachandran A, Snehalatha C, Satyavani K, Latha E, Sasikala R, Vijay V. Prevalence of vascular complications and their risk factors in type 2 diabetes. J Assoc Physicians India. 1999 Dec;47(12):1152-6.
  2. Mohan V, Premalatha G, Sastry NG. Peripheral vascular disease in non-insulin-dependent diabetes mellitus in south India. Diabetes Res Clin Pract. 1995 Mar;27(3):235-40.
  3. John L, Rao PS, Kanagasabapathy AS. Prevalence of diabetic nephropathy in non-insulin dependent diabetics. Indian J Med Res. 1991 Feb;94:24-9.
  4. Ding H, Triggle CR. Endothelial Cell Dysfunction and the Vascular Complications Associated with Type 2 Diabetes: Assessing the Health of the Endothelium. Vascular Health and Risk Management. 2005;1(1):55-71.
  5. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993 Dec;88(6):2510-6.
  6. Mohan V, Venkatraman JV, Pradeepa R. Epidemiology of Cardiovascular Disease in Type 2 Diabetes: The Indian Scenario. Journal of Diabetes Science and Technology. 2010;4(1):158-170.
  7. Eapen D, Kalra GL, Merchant N, Arora A, Khan BV. Metabolic syndrome and cardiovascular disease in South Asians. Vascular Health and Risk Management. 2009;5:731-743.
  8. Veale H. Note on Esbach’s Method for Estimating the Quantity of Albumen in Urine. British Medical Journal. 1884;1(1219):898.
  9. Kenny AP. The determination of cholesterol by the Liebermann-Burchard reaction. Biochemical Journal. 1952;52(4):611-619.
  10. Ahsan S, Basit A, Ahmed KR, Ali L, Shaheen F, Ulhaque MS, Fawwad A. Diagnostic accuracy of direct ophthalmoscopy for detection of diabetic retinopathy using fundus photographs as a reference standard. Diabetes Metab Syndr. 2014 Apr-Jun;8(2):96-101.
  11. Aronow WS. Peripheral arterial disease of the lower extremities. Archives of Medical Science : AMS. 2012;8(2):375-388.
  12. Khosla HL, Caroli RK, Bahl AL. Peripheral vascular disease in diabetes mellitus - A clinical study. Ind J Med Sci 1966; 20:698.
  13. Pathania NS, Sachar RS. Cardiovascular complications of diabetes mellitus based on a study of 349 cases. Br Med J. 1961 May 27;1(5238):1505-8.
  14.  Chakravarti A. Ind Heart J 1949; 1: 101.
  15. Banerjee JC. Cardiovascular complications in diabetes mellitus. Ind Ht Jr 1966; 11:55.
  16. Aggrawal BL. A study of cardiovascular status in long term diabetes. JAPI 1977; 25:845.
  17. Vaishnava H, Hagroo AA. Clinical and metabolic profile in diabetic cardiovascular disease. J Indian Med Assoc. 1973 Aug 16;61(4):159-66.
  18. Mathew JD. Vascular disease in diabetes mellitus. Lancet. 1954 Sep 18;267(6838):573–575.
  19. Raheja BS, Talwalkar NG, Suttarwalla SK. Ischaemic Heart Disease in Diabetes. Journal of Association of Physicians in India 1970; 18(2): 261-7.
  20. Samanta A, Burden AC, Jagger C. A comparison of the clinical features and vascular complications of diabetes between migrant Asians and Caucasians in Leicester, U.K. Diab Res Clin Prac 1991;14:205-214.
  21. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001 Apr;37(4):1053-9
  22. Lal HB, Bahl AL. Association of diabetes mellitus, hypertension and coronary heart disease. Indian Heart J. 1967 Apr;19(2):96–104. 
  23. Bryfogle JW, Bradley RF. The vascular complications of diabetes mellitus; a clinical study. Diabetes. 1957 Mar-Apr;6(2):159-67.
  24. Shah SK, Saikia M, Burman NN, Snehalatha C, Ramachandran A. High prevalence of type 2 diabetes in urban population in north eastern India. Int J Diabetes Dev Countries 1999; 19 : 144-7.
  25. Udani PM, Shah PM, Karani AN. Diabetes in children. Clinical and biochemical aspects. Indian Pediatr. 1968;5:391–400. 
  26. Tsai EC, Hirsch IB, Brunzell JD and Chait A: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. 1994: 43;1010 –1014.
  27. Enkins AJ, Klein RL, Chassereau CN, Hermayer KL and LopesVirella MF: LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. 1996: 45;762–767.
  28. Patel CA, Pathak NL, Bhatt N, Marya B, Gavania M, Trivedi H. Review: Cardio vascular complication of Diabetes MellitusJournal of Applied Pharmaceutical Science 01 (04); 2011: 01-06.
  29. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113:791–8.
  30. Ng D. Diabetic dyslipidemia: from evolving pathophysiological insight to emerging therapeutic targets. Can J Diabetes 2013; 37:319–26.

Corresponding Author

Dr Chandra Narayan Gupta

Associate Professor, Department of General Medicine, ICARE Institute of Medical Sciences and Research, Haldia, West Bengal 721645, India

Ph: +91- 9832197488 (M), Email: This email address is being protected from spambots. You need JavaScript enabled to view it.